Table 1:
Breast cancer cases (n=3368) | ||
---|---|---|
N | % | |
Demographics1 | ||
Age at cancer diagnosis | ||
65–69 | 840 | 24.9 |
70–74 | 1035 | 30.7 |
75–79 | 899 | 26.7 |
≥ 80 | 594 | 17.6 |
Race/ethnicity | ||
Non-Hispanic White | 3045 | 90.4 |
African American or Black | 180 | 5.3 |
Non-White/non-Black | 143 | 4.2 |
Residence at diagnosis, percent urban | ||
0 | 154 | 4.8 |
1–49 | 218 | 6.8 |
50–99 | 614 | 19.2 |
100 | 2210 | 69.1 |
Education | ||
High school diploma/GED or less | 626 | 18.7 |
School after high school | 1232 | 36.8 |
College degree or higher | 1492 | 44.5 |
Body-mass index( kg/m2) | ||
<25 | 1109 | 33.2 |
25 – <30 | 1147 | 34.3 |
>=30 | 1087 | 32.5 |
Smoking status | ||
Never | 1644 | 49.5 |
Past | 1516 | 45.7 |
Current | 158 | 4.8 |
Charlson comorbidity score3 | ||
0 | 2482 | 73.7 |
1 | 611 | 18.1 |
2+ | 275 | 8.2 |
Tumor characteristics | ||
Summary Stage | ||
Localized | 2669 | 79.2 |
Regional | 699 | 20.8 |
Tumor size (cm) | ||
≤1 | 1358 | 40.3 |
>1–2 | 1285 | 38.2 |
>2–5 | 565 | 16.8 |
>5 | 64 | 1.9 |
Unknown | 96 | 2.9 |
Nodal involvement | ||
No | 2667 | 79.2 |
Yes | 662 | 19.7 |
Unknown | 39 | 1.2 |
ER receptor | ||
Positive | 2787 | 82.7 |
Negative | 426 | 12.6 |
Unknown | 155 | 4.6 |
PR receptor | ||
Positive | 2399 | 71.2 |
Negative | 795 | 23.6 |
Unknown | 174 | 5.2 |
Her2-neu receptor | ||
Positive | 345 | 10.2 |
Negative | 2367 | 70.3 |
Unknown | 656 | 19.5 |
Triple negative | ||
No | 3131 | 93.0 |
Yes | 237 | 7.0 |
Cancer treatment2 | ||
Chemotherapy | ||
No | 2724 | 80.9 |
Yes | 644 | 19.1 |
Surgery type and radiation | ||
Breast-conserving with no radiation | 361 | 10.7 |
Breast conserving with radiation | 1945 | 57.8 |
Mastectomy with no radiation | 852 | 25.3 |
Mastectomy with radiation | 210 | 6.2 |
Demographic characteristics as collected at enrollment in the Women’s Health Initiative, except as noted.
Derived from Medicare claims data